AP-202

N/A

Report date: 2024/12/10 15:07:40
NME

Base Information

Drug NameAP-202
Drug Alias NameAP-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor; alpha4/beta2 antagonists
TargetsNeuronal acetylcholine receptor alpha4/beta2 complex
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAssuage Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAssuage Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsTobacco Use Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A